Cyclohexanemethylamine → HCID 86657552, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][C:11]([C:17]2[CH:22]=[C:21]([C:23]([F:26])([F:25])[F:24])[CH:20]=[C:19]([C:27]([F:30])([F:29])[F:28])[CH:18]=2)([C:14](O)=[O:15])[CH2:10][CH2:9]1)=O)(C)(C)C.[CH:31]1([CH2:37][NH2:38])[CH2:36][CH2:35][CH2:34][CH2:33][CH2:32]1.C(N(C(C)C)CC)(C)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C>[CH:31]1([CH2:37][NH:38][C:14]([C:11]2([C:17]3[CH:18]=[C:19]([C:27]([F:29])([F:28])[F:30])[CH:20]=[C:21]([C:23]([F:26])([F:25])[F:24])[CH:22]=3)[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]2)=[O:15])[CH2:36][CH2:35][CH2:34][CH2:33][CH2:32]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-(3,5-bis-trifluoromethylphenyl)-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester (0.5 mmol; 220.7 mg) in DMF (2 mL) was added cyclohexylmethylamine (0.6 mmol; 0.078 mL), N, N-diisopropyl-N-ethylamine (1 mmol; 0.174 mL) and HBTU (0.6 mmol; 228 mg), and the resulting mixture was stirred at room temperature overnight. The mixture was then purified via reverse phase HPLC. The desired fractions were combined and lyophilized. The resulting residue was dissolved in 1,4-dioxane (3 mL) and a 4N HCl solution in 1,4-dioxane (3 mL) was added. The resulting mixture was stirred for 2 hours at room temperature, then evaporated to yield 4-(3,5-bis-trifluoromethylphenyl)-piperidine-4-carboxylic acid cyclohexylmethylamide as a hydrochloride salt. MS (ESI) m/z 437.3 [M+H]+.
Workup
- customThe mixture was then purified via reverse phase HPLC
- dissolutionThe resulting residue was dissolved in 1,4-dioxane (3 mL)
- additiona 4N HCl solution in 1,4-dioxane (3 mL) was added
- stirringThe resulting mixture was stirred for 2 hours at room temperature
- customevaporated
Sources & evidence
- ORD record
- ord-410f9740844d48ab809484b7f851cfca
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08686152B2
Reaction notes
Loading…